Catalyst Wire Dossier Catalyst Wire Dossier

atezolizumab + bevacizumab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for atezolizumab + bevacizumab, covering 2018-11-15 to 2018-11-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma [Phase 3]

See pricing